Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Pilote: Mortality rates in elderly patients who take different angiotensin-converting enzyme.... (0.10 sec) 

Mortality rates in elderly patients who take different angiotensin-converting enzyme inhibitors …

- annals.org [PDF] 
L Pilote, M Abrahamowicz, E Rodrigues, MJ … - Annals of internal medicine, 2004 - Am Coll Physicians
Background: Several randomized, controlled trials show that
angiotensin-converting enzyme (ACE) inhibitors improve survival in patients who
have had an acute myocardial infarction. How- ever, existing data from ...
Cited by 81 - Related articles - All 8 versions

Is improved survival a class effect of angiotensin-converting enzyme inhibitors?


S Hennessy, SE Kimmel - Annals of internal medicine, 2004 - Am Coll Physicians
Randomized trials have shown that several but not all angiotensin-converting
enzyme (ACE) inhibitors, when given at specific doses, increase survival in
specific populations of patients with heart disease. Whether improved ...
Cited by 18 - Related articles - BL Direct - All 4 versions

Effect of different angiotensin-converting-enzyme inhibitors on mortality among elderly …

- ecmaj.ca
L Pilote, M Abrahamowicz, M Eisenberg, K … - Canadian Medical Association Journal, 2008 - Can Med Assoc
Methods: Using linked hospital discharge and prescription claims databases in
Quebec, Ontario and British Columbia, we identified all patients 65 years or
older who were admitted to hospital because of congestive heart failure ...
Cited by 10 - Related articles - BL Direct - All 19 versions

[PDF] Mechanisms of cardiovascular risk reduction with ramipril: insights from HOPE and HOPE …


E Lonn, HC Gerstein, M Smieja, JFE Mann, S … - European Heart Journal Supplements, 2003 - Eur Soc Cardiology
The importance of blood pressure (BP) lowering as a mechanism contributing to
the significant clinical benefits observed in the HOPE trial has been
controversial and much debated. Several lines of evidence suggest that in ...
Cited by 16 - Related articles - BL Direct - All 3 versions

ACE inhibition in stable coronary artery disease

- shouxi.net
S Yusuf, J Pogue, MG Myers, C McCullough, … - The New England Journal of Medicine, 2005 - nejm.highwire.org
1. Rocha V, Chevret S, Ionescu I, et al. Incidence and risk factors of early
severe infections after unrelated cord blood transplantation: a Eurocord-Netcord
analysis. Blood 2004;104:590a. abstract. 2. Rocha V, Labopin M, Sanz G, et ...
Cited by 42 - Related articles - All 5 versions

Different angiotensin-converting enzyme inhibitors have similar clinical efficacy after …


ML Hansen, GH Gislason, L Køber, TK … - British Journal of Clinical Pharmacology, 2008 - pubmedcentral.nih.gov
Adjusted Cox regression analysis demonstrated no differences in risk for
all-cause mortality, but patients using captopril had higher risk of
reinfarction (hazard ratio 1.18, 95% confidence interval 1.05, 1.34). ...
Cited by 6 - Related articles - BL Direct - All 6 versions

Decreased glomerulosclerosis in aging by angiotensin-converting enzyme inhibitors

- asnjournals.org [PDF] 
L Ferder, F Inserra, L Romano, L Ercole, V … - Journal of the American Society of Nephrology, 1994 - Am Soc Nephrol
L. Ferder, F. Inserra. L. Romano. L. Ercole. V. Pszenny. Institute of
Nephrology. Jewish Hospital of Buenos Aires. University of Buenos Aires, Buenos
Aires, Argen- tina (J. Am. Soc. Nephrol. 1994; 5:1 147-1 152)
Cited by 28 - Related articles - BL Direct - All 4 versions

Class effect of angiotensin-converting enzyme inhibitors on prevention of myocardial …


WH Sauer, JT Baer, JA Berlin, SE Kimmel - The American journal of cardiology, 2004 - Elsevier
Angiotensin-converting-enzyme (ACE) inhibition decreases the risk of myocardial
infarction (MI) in a way that may be independent of its ability to decrease
blood pressure. 1 and 2 This decrease in MI risk may be due to inhibition ...
Cited by 10 - Related articles - All 7 versions

Treatment benefit by perindopril in patients with stable coronary artery disease at different …

- oxfordjournals.org
JW Deckers, DM Goedhart, E Boersma, A … - European heart journal, 2006 - Eur Soc Cardiology
Methods and results A total of 12 218 patients with stable CAD were treated with
8 mg perindopril or placebo. Baseline patient characteristics were assessed for
association with 1091 cardiovascular deaths or non-fatal myocardial ...
Cited by 34 - Related articles - BL Direct - All 4 versions

The effect of perindopril on cardiovascular morbidity and mortality in patients with …

- oxfordjournals.org
CA Daly, KM Fox, WJ Remme, ME Bertrand, R … - European heart journal, 2005 - Eur Soc Cardiology
Methods and results A total of 1502 diabetic patients with known coronary artery
disease and without heart failure of 12 218 overall in the EUropean trial on
Reduction Of cardiac events with Perindopril in stable coronary Artery ...
Cited by 37 - Related articles - All 11 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google